Securities code: Suzhou Medicalsystem Technology Co.Ltd(603990) securities abbreviation: Suzhou Medicalsystem Technology Co.Ltd(603990) Announcement No.: 2022035 Suzhou Medicalsystem Technology Co.Ltd(603990)
Announcement on the cancellation of unanimous action agreement by shareholders
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and completeness of its contents.
Suzhou Medicalsystem Technology Co.Ltd(603990) (hereinafter referred to as “the company” or ” Suzhou Medicalsystem Technology Co.Ltd(603990) “) recently received a notice of the cancellation of the agreement on concerted action signed by Mr. Weng Kang, the controlling shareholder and actual controller of the company, and Ms. Yan huanghong, the person acting in concert. The specific situation is hereby announced as follows:
1、 Signing and performance of the original agreement on concerted action
Mr. Weng Kang, the controlling shareholder and actual controller of the company, and Ms. Yan huanghong signed the agreement on concerted action on October 13, 2017. Both parties took concerted action in the decision-making process of major matters of the company, including but not limited to: deciding the company’s business plan and investment plan, deciding the company’s profit distribution plan and implementation, submitting proposals to the general meeting of shareholders and the board of directors, and voting on such proposals, directors of the company The nomination, appointment and removal of supervisors and senior managers, the decision to increase or reduce the registered capital of the company, and other major matters that should be decided by the general meeting of shareholders and the board of directors as stipulated in the articles of association. Both parties shall make the same decisions or voting opinions and act in concert when exercising the rights of shareholders and attending the general meeting of shareholders without violating the provisions of mandatory laws and regulations.
After the signing of the agreement on concerted action, all parties concerned have complied with the agreement and commitment on concerted action, and there is no violation of the agreement and commitment on concerted action.
2、 Relevant information on the dissolution of the relationship through concerted action
After friendly negotiation, Mr. Weng Kang and Ms. Yan huanghong signed the termination agreement of the agreement on concerted action on May 23, 2022. The main contents are as follows:
(I) from the effective date of this agreement, the relationship between both parties shall be terminated by concerted action, including:
1. The agreement on concerted action signed by both parties is terminated, and all terms under the agreement on concerted action are no longer binding on all parties;
2. Both parties confirm that since the effective date of this agreement, both parties no longer have any concerted action or similar arrangements.
(II) after the termination of the relationship of concerted action by both parties, there is no need for both parties to maintain concerted action in Suzhou Medicalsystem Technology Co.Ltd(603990) operation and management and decision-making on major matters. Both parties will independently exercise shareholders’ rights and perform shareholders’ obligations in accordance with laws, regulations, normative documents and the provisions of Suzhou Medicalsystem Technology Co.Ltd(603990) the articles of association.
(III) both parties confirm that during the period of the relationship of concerted action, both parties have complied with the provisions of the agreement, there is no violation of the agreement, and there is no dispute or dispute between both parties on the performance and dissolution of the relationship of concerted action.
(IV) both parties shall cooperate and timely perform relevant information disclosure obligations in accordance with relevant laws, regulations, normative documents and the requirements of regulatory authorities.
As of the disclosure date of this announcement, the number of shares held by Mr. Weng Kang and Ms. Yan huanghong remained unchanged before and after the dissolution of the relationship. The specific shareholding conditions are as follows:
Serial number of the total share capital of the company shareholder name number of shares held (shares)
Proportion (%)
1 wengkang 2187276013.22%
2 Yan huanghong 55697983.37%
Total 274425816.59%
3、 Other relevant instructions
(I) the dissolution of the company’s shareholders’ concerted action relationship will not violate the provisions of relevant laws, regulations and normative documents such as the company law, the securities law, the measures for the administration of the acquisition of listed companies, the stock listing rules of Shanghai Stock Exchange, and will not lead to changes in the company’s main business structure and adverse effects on the company’s daily business activities, It will not have a significant impact on the company’s main business and financial status, and will not affect the personnel independence, financial independence and Asset Integrity of listed companies. The company still has a standardized corporate governance structure. (II) the shareholders of the company shall change the control of the company while terminating the relationship of concerted action. For details, see the progress announcement of Suzhou Medicalsystem Technology Co.Ltd(603990) on the signing of share transfer agreement by controlling shareholders, actual controllers, persons acting in concert and other shareholders, the signing of share subscription agreement with conditional effect by the company and the proposed change of controlling shareholders and actual controllers disclosed by the company on the same day. This matter will lead to the change of controlling shareholders When the actual controller changes, Mianyang Haoxiang Holding Co., Ltd. will become the controlling shareholder of the listed company, and Mianyang Anzhou District State owned assets supervision and administration office will become the actual controller of the listed company.
(III) the information disclosure obligors involved in the cancellation of the unanimous action agreement by the shareholders of the company still need to prepare the equity change report. The company will perform the obligation of announcement in time after receiving the reports and opinions submitted by the above information disclosure obligors.
Please invest rationally and pay attention to investment risks.
4、 Documents for future reference
The cancellation agreement of the agreement on concerted action signed by Mr. Weng Kang and Ms. Yan huanghong.
It is hereby announced
Suzhou Medicalsystem Technology Co.Ltd(603990) board of directors may 24, 2022
